跳至主要内容
临床试验/JPRN-UMIN000008049
JPRN-UMIN000008049已完成4 期

Efficacy of Ezetimibe vs Rosuvastatin In Impaired Glucose Tolerance Hypercholesterolemia to Treat - Efficacy of Ezetimibe vs Rosuvastatin In Impaired Glucose Tolerance Hypercholesterolemia to Treat (E-RIGHT study)

Jikei University School of Medicine,Kashiwa Hospital0 个研究点目标入组 150 人开始时间: 2012年5月30日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) HbA1c>=6.5%(NGSP) 2) Hypersensitivity to test agents 3) Treating with antihyperlipidemic agents other than rosuvastatin 4) Severe hepatic dysfunction: any one of following (i)AST>=100IU/L (ii)ALT>=100IU/L (iii)Cirrhosis 5) Severe renal dysfunction: serum creatinine>=2.0mg/dL 6) History of acute coronary syndrome(myocardial infarction, angina) and stroke within 3 months 7) Secondary hyperlipidemia, drug induced hyperlipidemia 8) Pregnant, breast-feeding, becoming pregnant 9) Familial hypercholesterolemia 10) Inadequate to this study

研究者

发起方
Jikei University School of Medicine,Kashiwa Hospital

相似试验

Efficacy of Ezetimibe vs Rosuvastatin In Impaired... | 临床试验